Copyright
©The Author(s) 2024.
World J Hepatol. Nov 27, 2024; 16(11): 1282-1289
Published online Nov 27, 2024. doi: 10.4254/wjh.v16.i11.1282
Published online Nov 27, 2024. doi: 10.4254/wjh.v16.i11.1282
Figure 2 Expression of proteasome 26S subunit non-ATPase 6 protein in normal intrahepatic bile duct epithelial tissues and intrahepatic cholangiocarcinoma tissues.
A: HPA036921 antibody; patient ID: 2429; normal bile duct cells; staining: Negative; intensity: Negative; quantity: 0; B: HPA036922 antibody; patient ID: 3222; normal bile duct cells; staining: Negative; intensity: Negative; quantity: 0. Images represent the tissue at 20 μm magnification; C: HPA036921 antibody; patient ID: 3625; intrahepatic cholangiocarcinoma (ICC) cells; staining: High; intensity: Strong; quantity: > 75%; localization: Cell membrane/cytoplasm; D: HPA036922 antibody; patient ID: 3625; ICC cells; staining: Moderate; intensity: Moderate; quantity: > 75%; localization: Nucleus. Images represent the tissue at 20 μm magnification.
- Citation: Tang ZQ, Tang YL, Qin K, Li Q, Chen G, Huang YB, Li JJ. Overexpression of proteasome 26S subunit non-ATPase 6 protein and its clinicopathological significance in intrahepatic cholangiocarcinoma. World J Hepatol 2024; 16(11): 1282-1289
- URL: https://www.wjgnet.com/1948-5182/full/v16/i11/1282.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i11.1282